PKY Pathkey.AI Ltd
Healthcare · Health Information Services
· website
$0.02
52wk 0.01 – 0.07
Overall
41.7
Value
66.6
Growth
0.0
Health
100.0
Quality
0.0
Momentum
27.8
Dividend
—
Price
About Pathkey.AI Ltd
Pathkey.AI Ltd, a technology company, develops agentic AI solutions in Australia. The company offers Chipforge, an AI-native semiconductor design and verification platform. It also provides Trialkey, an AI platform for clinical-trial design and prediction. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Sydney, Australia.
Price analytics
Returns
| 1 day | 0.0% |
| 1 week | -7.7% |
| 1 month | -35.1% |
| 3 months | -57.1% |
| 6 months | 9.1% |
| 1 year | -4.0% |
| 3 years | -44.4% |
Risk
| Volatility (1y ann.) | 131.5% |
| Beta vs ASX 200 | 1.04 |
| Sharpe (1y) | 0.56 |
| VaR 95% (1-day) | -10.5% |
| Max drawdown (1y) | -66.2% |
| Off 1-year high | -66.2% |
Technicals
| RSI(14) | 29 OS |
| vs 50DMA | -28.0% |
| vs 200DMA | -27.6% |
| Trend | Golden cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
66.6
Trailing P/E
—
Forward P/E
—
PEG ratio
50
EV / EBITDA
100
Price / Book
100
Price / Sales
0
Growth
0.0
Revenue growth (1y)
0
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health
100.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
100
Debt / Equity
—
Quality (Profitability & Cash Flow)
0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income
—
No meaningful dividend — pillar excluded from the overall score.
Momentum
27.8
6-month return vs ASX 200
76
Price vs 200-day average
0
Price vs 50-day average
0
Position in 52-week range
18
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$32.44M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
-0.01
Dividend yield
—
Payout ratio
0.0%
Beta
1.45
EV / EBITDA
-6.99
Price / Book
0.73
ROE
-18.5%
Operating margin
-8,022.3%
Net margin
0.0%
Total cash
$3.41M
Total debt
$0
Current ratio
7.59
Debt / Equity
—
Free cash flow
$-3,022
Avg volume
4.10M
Latest annual results
(FY ending 30 Jun 2025)
- Revenue—
- Gross profit—
- Operating income—
- Net income—
- Diluted EPS-0.01
- Free cash flow—
- Net debt—